Augmentation of selective serotonin reuptake inhibitor antidepressant efficacy with pindolol and the relevance of 5HT1A autoreceptors
β Scribed by Matthew P. Galloway
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 505 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1070-9797
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Co-administration of pindolol with SSRIs in patients with depression has been suggested as a way to both hasten and augment antidepressant response. Clinical trials have examined the efficacy of this treatment regime and conflicting results have been reported. The present review briefly presents the
## Abstract ## Objective To investigate the comparative efficacy of aripiprazole and risperidone as augmenting agents in the treatment of obsessiveβcompulsive disorder (OCD) patients who did not show a β₯35% decrease in the YaleβBrown ObsessiveβCompulsive Scale (YβBOCS) after 12βweek monotherapy wi